Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Titel:
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Auteur:
Rozeman, Elisa A Menzies, Alexander M van Akkooi, Alexander C J Adhikari, Chandra Bierman, Carolien van de Wiel, Bart A Scolyer, Richard A Krijgsman, Oscar Sikorska, Karolina Eriksson, Hanna Broeks, Annegien van Thienen, Johannes V Guminski, Alexander D Acosta, Alex Torres ter Meulen, Sylvia Koenen, Anne Miek Bosch, Linda J W Shannon, Kerwin Pronk, Loes M Gonzalez, Maria Ch'ng, Sydney Grijpink-Ongering, Lindsay G Stretch, Jonathan Heijmink, Stijn van Tinteren, Harm Haanen, John B A G Nieweg, Omgo E Klop, Willem M C Zuur, Charlotte L Saw, Robyn P M van Houdt, Winan J Peeper, Daniel S Spillane, Andrew J Hansson, Johan Schumacher, Ton N Long, Georgina V Blank, Christian U